Actinium Pharmaceuticals (ATNM) Q1 2026 Earnings
ATNM·Reported May 8, 2026·After market close
Diluted EPS came in at $-0.18 (+64.7% YoY), beat the $-0.22 consensus by $0.04.
Diluted EPS
$-0.18beat by $0.04
Consensus: $-0.22
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Actinium Pharmaceuticals's Q1 2026 earnings report.
Actinium Pharmaceuticals (ATNM) reported Q1 2026 earnings on May 8, 2026 after market close.
Actinium Pharmaceuticals reported diluted EPS of $-0.18 for Q1 2026.
EPS beat the consensus estimate of $-0.22 by $0.04.
Compared to the same quarter a year prior, diluted EPS grew 64.7% from $-0.51.
You can read the 10-Q periodic report (0001213900-26-053980) directly on SEC EDGAR. The filing index links above go to sec.gov.